In cisplatin-resistant human lung cancer cells, FTY720 combined with cisplatin enhanced the antitumor effect of cisplatin on cisplatin-resistant lung cancer cells by down-regulating the expression of Atg7 [19]. Here, ATG7 is linked to lung carcinoma.